Ashwini Deshpande
Ashwini Deshpande
Professor- Pharmaceutics
Verified email at nmims.edu
Title
Cited by
Cited by
Year
Kinetic modeling and dissolution profiles Comparison: an overview
SD Hussain Lokhandwala, Ashwini Deshpande
International Journal of Pharma and Bio Sciences 4 (1), 728-737, 2013
622013
Co-crystallization-a technique for solubility enhancement
T Patole, A Deshpande
Int J Pharm Sci Res 5 (9), 3566-76, 2014
272014
Nanostructured lipid carriers-based drug delivery for treating various lung diseases: a state‐of‐the‐art review
TS Patil, AS Deshpande
International journal of pharmaceutics 547 (1-2), 209-225, 2018
172018
Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need
TS Patil, AS Deshpande, S Deshpande, P Shende
Journal of Drug Targeting 27 (1), 12-27, 2019
112019
Preparation and evaluation of cyclodextrin based atorvastatin nanosponges
A Deshpande, P Patel
Am. J. PharmTech Res 4 (3), 2249-3387, 2014
102014
Various treatments for vitiligo: Problems associated and solutions
DM Lakhani, AS Deshpande
Journal of Applied Pharmaceutical Science 4 (11), 101-105, 2014
92014
Kinetic modeling and comparison of invitro dissolution profiles
AD Jitendra C. Shah
WORLD JOURNAL OF PHARMACEUTICAL SCIENCES 2 (4), 302-309, 2014
82014
Patent review on cyclodextrin based nanosponges prepared by different methods: Physicochemical characterization, factors influencing formation and applications
AD Pritesh Patel
WORLD JOURNAL OF PHARMACEUTICAL SCIENCES 2 (4), 380-385, 2014
72014
Critical Review on the Analytical Methods for the Estimation of Clofazimine in Bulk, Biological Fluids and Pharmaceutical Formulations
SD Tulshidas S. Patil, Ashwini S. Deshpande
Critical Reviews in Analytical Chemistry, 2018
62018
Development of an Innovative Quality by Design (QbD) based stability-indicating HPLC method and its validation for clofazimine from its bulk and pharmaceutical dosage forms
TS Patil, AS Deshpande
Chromatographia 82 (2), 579-590, 2019
42019
Invitro release comparison of nifedipine from marketed and prepared controlled release Formulations by mathematical modeling
HL Ashwini Deshpande, Shirish Deshpande
International Journal of Pharma and Bio Sciences 4 (2), 717-726, 2013
42013
Mannosylated nanocarriers mediated site-specific drug delivery for the treatment of cancer and other infectious diseases: A state of the art review
TS Patil, AS Deshpande
Journal of Controlled Release 320, 239-252, 2020
32020
Evaluation of Nanocarrier-Based Dry Powder Formulations for Inhalation with Special Reference to Anti-Tuberculosis Drugs
TS Patil, A Deshpande, PK Shende, S Deshpande, R Gaud
Critical Reviews™ in Therapeutic Drug Carrier Systems 36 (3), 2019
32019
Orodispersible Films: A systematic patent review
C Gijare, A Deshpande
Recent patents on drug delivery & formulation 12 (2), 110-120, 2018
32018
Innovative strategies in the diagnosis and treatment of tuberculosis: a patent review (2014–2017)
TS Patil, AS Deshpande
Expert Opinion on Therapeutic Patents 28 (8), 615-623, 2018
22018
Antiobesity Potential of Fresh Cow Urine and its Distillate - A Biomedicine for Tomorrow
S712 Indian Journal of Pharmaceutical Education and Research | 51 (4s), 712 …, 2017
2*2017
The emergence of time programmed drug delivery system: chronotherapy of cardio vascular diseases
V Singh, A Deshpande
Int J Pharm Pharm Sci 6 (10), 56-60, 2014
22014
Formulation and evaluation of orally disintegrating tablets of ondansetron hydrochloride by sublimation technique
A Deshpande, DK Patel
Int. J. Biopharmaceutics 5 (3), 163-170, 2014
22014
Spherical Crystallization as Particle Engineering Technique to Improve Processability of Poor Flowing Furosemide
SD Dhanashri Kabra, Ashwini Deshpande
International Journal of Pharmaceutical Sciences and Nanotechnology 6 (1 …, 2013
22013
Nanocarrier technologies for enhancing the solubility and dissolution rate of API
A Deshpande, TS Patil
Medicinal Chemistry with Pharmaceutical Product Development, 155-233, 2019
12019
The system can't perform the operation now. Try again later.
Articles 1–20